Kathryn Anne Bowman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Fc | 1 | 2023 | 541 | 0.720 |
Why?
|
Viral Vaccines | 1 | 2022 | 636 | 0.570 |
Why?
|
Antibodies | 2 | 2023 | 2460 | 0.550 |
Why?
|
Immunoglobulin Isotypes | 1 | 2023 | 158 | 0.230 |
Why?
|
Immunity, Humoral | 3 | 2022 | 598 | 0.210 |
Why?
|
Saponins | 1 | 2021 | 50 | 0.200 |
Why?
|
Mycobacterium tuberculosis | 2 | 2023 | 1832 | 0.180 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.170 |
Why?
|
Antibodies, Viral | 4 | 2022 | 3176 | 0.170 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 173 | 0.170 |
Why?
|
Antibodies, Neutralizing | 3 | 2022 | 1978 | 0.160 |
Why?
|
Tuberculosis | 2 | 2023 | 1912 | 0.160 |
Why?
|
Immunity | 1 | 2023 | 1012 | 0.150 |
Why?
|
Toll-Like Receptor 2 | 1 | 2018 | 354 | 0.140 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1990 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2020 | 847 | 0.130 |
Why?
|
Vaccination | 3 | 2022 | 3278 | 0.120 |
Why?
|
Interleukin-2 | 1 | 2018 | 1904 | 0.100 |
Why?
|
Membrane Glycoproteins | 1 | 2018 | 3768 | 0.080 |
Why?
|
RNA, Messenger | 1 | 2022 | 13033 | 0.070 |
Why?
|
AIDS Vaccines | 1 | 2013 | 938 | 0.070 |
Why?
|
HIV | 1 | 2013 | 1604 | 0.070 |
Why?
|
Macaca mulatta | 2 | 2022 | 2375 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 1838 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 2 | 2023 | 2559 | 0.050 |
Why?
|
HIV Infections | 2 | 2023 | 16718 | 0.050 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2021 | 370 | 0.050 |
Why?
|
Intubation | 1 | 2020 | 141 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4386 | 0.050 |
Why?
|
Respiratory Therapy | 1 | 2020 | 132 | 0.040 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2021 | 482 | 0.040 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2021 | 279 | 0.040 |
Why?
|
Viremia | 1 | 2022 | 736 | 0.040 |
Why?
|
Primates | 1 | 2021 | 545 | 0.040 |
Why?
|
Viral Load | 2 | 2020 | 3299 | 0.040 |
Why?
|
Mycobacterium bovis | 1 | 2018 | 150 | 0.040 |
Why?
|
South Africa | 1 | 2023 | 1731 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2020 | 1850 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2618 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6473 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3206 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2018 | 810 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12026 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2749 | 0.030 |
Why?
|
Humans | 9 | 2023 | 744343 | 0.030 |
Why?
|
Haplotypes | 1 | 2018 | 2779 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2013 | 311 | 0.030 |
Why?
|
Virus Latency | 1 | 2013 | 358 | 0.020 |
Why?
|
Nanoparticles | 1 | 2021 | 1905 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4560 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2013 | 880 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2013 | 1821 | 0.020 |
Why?
|
Male | 5 | 2023 | 350118 | 0.020 |
Why?
|
Animals | 3 | 2022 | 168757 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2013 | 1873 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6622 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10180 | 0.010 |
Why?
|
Adult | 3 | 2023 | 214055 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13815 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 12072 | 0.010 |
Why?
|
Middle Aged | 3 | 2020 | 213383 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 18111 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4479 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15519 | 0.010 |
Why?
|
Female | 3 | 2021 | 380194 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17446 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35136 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81183 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39050 | 0.010 |
Why?
|
Aged | 1 | 2020 | 163280 | 0.000 |
Why?
|